Vimian Group AB (publ) (VIMGF)
OTCMKTS · Delayed Price · Currency is USD
4.300
0.00 (0.00%)
At close: Jul 14, 2025
Theseus Pharmaceuticals Market Cap
Vimian Group AB has a market cap or net worth of $1.84 billion as of July 31, 2025. Its market cap has increased by 4.66% in one year.
Market Cap
1.84B
Enterprise Value
2.11B
Revenue
474.81M
Ranking
n/a
PE Ratio
68.83
Stock Price
$4.30
Market Cap Chart
Since June 18, 2021, Vimian Group AB's market cap has decreased from 3.65B to 1.84B, a decrease of -49.44%. That is a compound annual growth rate of -15.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 1.84B | -2.24% |
| Dec 30, 2024 | 1.89B | 40.53% |
| Dec 29, 2023 | 1.34B | 23.45% |
| Dec 30, 2022 | 1.09B | -68.17% |
| Dec 30, 2021 | 3.41B | -6.35% |
| Jun 18, 2021 | 3.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 590.95M |
| Glass House Brands | 435.80M |
| Northwest Biotherapeutics | 379.00M |
| CytoDyn | 371.09M |